Pfizer's acquisition of biotechnology firm Metsera is expected to speed up its re-entry into the lucrative market for obesity treatments, currently dominated by Eli Lilly and Danish rival Novo Nordisk ...

Adriano Marchese writes about Canadian breaking business and financial news out of Toronto. Previously, he covered UK finance and business out of Barcelona, Spain. He is a graduate of the University ...